# Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety

> **NCT01567995** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 240 (actual)

## Conditions studied

- Eczema

## Interventions

- **DRUG:** Clobetasone Butyrate 0.05% Cream
- **DRUG:** Vehicle (base cream)

## Key facts

- **NCT ID:** NCT01567995
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02-28
- **Primary completion:** 2009-01-01
- **Final completion:** 2009-02-10
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2017-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01567995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01567995, "Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and Safety". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01567995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*